前收市價 | 1.0500 |
開市 | 1.1700 |
買盤 | 0.9500 |
賣出價 | 1.0700 |
拍板 | 30.00 |
到期日 | 2024-12-20 |
今日波幅 | 0.9900 - 1.1700 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 3.22k |
Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
An FDA panel endorses Eli Lilly's (LLY) Alzheimer's disease drug, donanemab. Pfizer's (PFE) DMD study on investigational gene therapy fails.